Deshan Li

发表

FGF21 exerts comparable pharmacological efficacy with Adalimumab in ameliorating collagen-induced rheumatoid arthritis by regulating systematic inflammatory response.

Dan Yu, X. Ye, Ruixiang Che, 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Recombinant murine fibroblast growth factor 21 ameliorates obesity-related inflammation in monosodium glutamate-induced obesity rats

Li-Hong Zhou, G. Ren, Deshan Li, 2015, Endocrine.

[Anti-tumor efficacy of P53 with 9R cell-penetrating peptides].

Yuquan Wei, N. Zhang, X. Ye, 2013, Sheng wu gong cheng xue bao = Chinese journal of biotechnology.

Pharmacological efficacy of anti-IL-1β scFv, Fab and full-length antibodies in treatment of rheumatoid arthritis.

X. Ye, J. Qi, G. Ren, 2014, Molecular immunology.

A novel function for fibroblast growth factor 21: stimulation of NADPH oxidase-dependent ROS generation

Deshan Li, Wen-Fei Wang, Lei Ma, 2015, Endocrine.

Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism.

C. Fraser, J. Hale, Deshan Li, 2005, Endocrinology.

Fibroblast growth factor 21 expressions in white blood cells and sera of patients with gestational diabetes mellitus during gestation and postpartum

Li-Hong Zhou, Deshan Li, Wen-Fei Wang, 2015, Endocrine.

THE STERATEGIC ROLE OF FIBROBLAST GROWTH FACTOR-21 IN OBESITY

Deshan Li, Y. Opoku, Amro Abdelazez, 2018 .

FGF21 attenuates pulmonary fibrogenesis through ameliorating oxidative stress in vivo and in vitro.

Dan Yu, Shengqi Zhang, Hongsong Wu, 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Insulin sensitizes FGF21 in glucose and lipid metabolisms via activating common AKT pathway

Dan Yu, X. Ye, Qiang Wu, 2016, Endocrine.

[Optimization and characterization of a novel FGF21 mutant].

Dan Yu, X. Ye, G. Ren, 2012, Yao xue xue bao = Acta pharmaceutica Sinica.

Use of viral vector to deliver IL-15 for cancer therapy: An Overview

Deshan Li, M. Khoso, L. M. Rasoul, 2017 .

Long-Term Administration of Fibroblast Growth Factor 21 Prevents Chemically-Induced Hepatocarcinogenesis in Mice

Yingjie Zhang, X. Ye, Qiang Wu, 2015, Digestive Diseases and Sciences.

Genetically engineered Newcastle disease virus expressing interleukin 2 is a potential drug candidate for cancer immunotherapy.

G. Ren, Deshan Li, H. Tian, 2014, Immunology letters.

Fibroblast growth factor 21 regulates glucose metabolism in part by reducing renal glucose reabsorption.

Xiaochen Guo, G. Ren, Deshan Li, 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Liver Plays a Major Role in FGF-21 Mediated Glucose Homeostasis

Deshan Li, Wen-Fei Wang, Ming-yao Liu, 2018, Cellular Physiology and Biochemistry.

Optimization of oncolytic effect of Newcastle disease virus Clone30 by selecting sensitive tumor host and constructing more oncolytic viruses

Zhenzhong Wang, W. Xiao, Qingzhong Yu, 2020, Gene Therapy.

Recombinant Newcastle disease virus (NDV/Anh-IL-2) expressing human IL-2 as a potential candidate for suppresses growth of hepatoma therapy.

Qingzhong Yu, X. Ye, J. Qi, 2016, Journal of pharmacological sciences.

Recombinant Newcastle Disease Virus Anhinga Strain (NDV/Anh-EGFP) for Hepatoma Therapy

Qingzhong Yu, G. Ren, Deshan Li, 2014, Technology in cancer research & treatment.

Fibroblast Growth Factor 21 Exerts its Anti‐inflammatory Effects on Multiple Cell Types of Adipose Tissue in Obesity

Yanhua Li, Deshan Li, Wen-Fei Wang, 2019, Obesity.

FGF21 ameliorates nonalcoholic fatty liver disease by inducing autophagy

Yuquan Wei, Dan Yu, X. Ye, 2016, Molecular and Cellular Biochemistry.

Fibroblast Growth Factor 21 Ameliorates Endothelin I-Induced Hypertension Partly Through PPAR γ Pathway

Deshan Li, S. Li, S. Shao, 2022, International Journal of Peptide Research and Therapeutics.

Fibroblast growth factor-21 as a novel metabolic factor for regulating thrombotic homeostasis

Xiaochen Guo, G. Ren, Deshan Li, 2022, Scientific Reports.

Evaluation of a cell model expressing βKlotho for screening FGF21 analogues

Xiaochen Guo, G. Ren, Deshan Li, 2019, Cytotechnology.

Fibroblast Growth Factor–21 Ameliorates Rheumatoid Arthritis by Maintaining Articular Integrity

Han Liu, G. Ren, Deshan Li, 2019, International Journal of Peptide Research and Therapeutics.

Anti-human fibroblast growth factor-21 monoclonal antibody preparation, characterization and analysis of in vitro bioactivity.

Deshan Li, Yin-hang Yu, L. Ding, 2016, Experimental and therapeutic medicine.

Fibroblast Growth Factor-21 Mediates Hepatic Glucose Metabolism of Type 1 Diabetes Model and Its Mechanism*: Fibroblast Growth Factor-21 Mediates Hepatic Glucose Metabolism of Type 1 Diabetes Model and Its Mechanism*

X. Ye, G. Ren, Deshan Li, 2011 .

Fibroblast growth factor 21 improves glucose homeostasis partially via down-regulation of Na+-d-glucose cotransporter SGLT1 in the small intestine.

Xiaochen Guo, G. Ren, Deshan Li, 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Fibroblast growth factor 21 (FGF21) ameliorates collagen-induced arthritis through modulating oxidative stress and suppressing nuclear factor-kappa B pathway.

G. Ren, Deshan Li, Zhiyi Zhang, 2015, International immunopharmacology.

[Cloning, expression and glucose regulation activity of human FGF-21].

G. Ren, Deshan Li, Wen-Fei Wang, 2010, Yi chuan = Hereditas.

Canine Fibroblast Growth Factor 21 Ameliorates Hyperglycemia Associated with Inhibiting Hepatic Gluconeogenesis and Improving Pancreatic Beta-Cell Survival in Diabetic Mice and Dogs

Qiang Wu, Liying Song, G. Ren, 2016, PloS one.

Fibroblast growth factor 21 (FGF21) inhibits macrophage-mediated inflammation by activating Nrf2 and suppressing the NF-κB signaling pathway.

Liying Song, Xiaochen Guo, G. Ren, 2016, International immunopharmacology.

FGF21 ameliorates hepatic fibrosis by multiple mechanisms

Deshan Li, Fanrui Meng, Wei Xiao, 2021, Molecular Biology Reports.

G. Ren, Deshan Li, Jiechao Yin, 2015, Technology in cancer research & treatment.

Genetically engineered Newcastle disease virus expressing interleukin-2 and TNF-related apoptosis-inducing ligand for cancer therapy

G. Ren, Deshan Li, Xiao-hui Han, 2014, Cancer biology & therapy.

Synergistic effects of interleukin-1β and interleukin-17A antibodies on collagen-induced arthritis mouse model.

Liming Xu, X. Ye, J. Qi, 2013, International immunopharmacology.

Fibroblast growth factor 21 regulates foam cells formation and inflammatory response in Ox-LDL-induced THP-1 macrophages.

Xiaochen Guo, Deshan Li, Wen-Fei Wang, 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

An efficient large-scale refolding technique for recovering biologically active recombinant human FGF-21 from inclusion bodies.

Dan Yu, X. Ye, Qiang Wu, 2019, International journal of biological macromolecules.

Pilot-scale production and characterization of PEGylated human FGF-21 analog.

Dan Yu, X. Ye, Qiang Wu, 2016, Journal of biotechnology.

Long-lasting hypoglycemic effect of modified FGF-21 analog with polyethylene glycol in type 1 diabetic mice and its systematic toxicity.

Dan Yu, X. Ye, Qiang Wu, 2016, European journal of pharmacology.

Fibroblast growth factor 21: a novel long-acting hypoglycemic drug for canine diabetes

Ruonan Zhang, G. Ren, Deshan Li, 2020, Naunyn-Schmiedeberg's Archives of Pharmacology.

The therapeutic effects of FGF21 on diabetic nephropathy are realized by augmenting autophagy via AMPK/mTOR signaling pathway

W. Xiao, G. Ren, Deshan Li, 2020 .

FGF-21 Plays a Crucial Role in the Glucose Uptake of Activated Monocytes

Deshan Li, Wen-Fei Wang, Si-ming Li, 2018, Inflammation.

FGF21 Enhances Therapeutic Efficacy and Reduces Side Effects of Dexamethasone in Treatment of Rheumatoid Arthritis

W. Xiao, Yanhua Li, Deshan Li, 2020, Inflammation.

Ameliorative effects of a fusion protein dual targeting interleukin 17A and tumor necrosis factor α on imiquimod-induced psoriasis in mice.

Han Liu, Dan Yu, Liying Song, 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

A novel fusion protein attenuates collagen–induced arthritis by targeting interleukin 17A and tumor necrosis factor &agr;

Han Liu, Dan Yu, Liying Song, 2018, International journal of pharmaceutics.

Therapeutic efficacy of three bispecific antibodies on collagen-induced arthritis mouse model.

Liming Xu, Qiang Wu, J. Qi, 2014, International immunopharmacology.

A bispecific antibody against IL-1β and IL-17A is beneficial for experimental rheumatoid arthritis.

X. Ye, J. Qi, G. Ren, 2012, International immunopharmacology.

The composite biological adjuvants enhance immune response of porcine circovirus type2 vaccine.

Xiaochen Guo, G. Ren, Deshan Li, 2019, Veterinary microbiology.

Recombinant NDV expressing cytokines or fliC confers a quick immune response against NDV challenge and resistance to maternal antibody.

Xu Zhang, G. Ren, Deshan Li, 2016, Veterinary microbiology.

Fibroblast growth factor 21 ameliorates pancreatic fibrogenesis via regulating polarization of macrophages.

Yanhua Li, Deshan Li, Wen-Fei Wang, 2019, Experimental cell research.

Fibroblast Growth Factor–21 ameliorates hepatic encephalopathy by activating the STAT3-SOCS3 pathway to inhibit activated hepatic stellate cells

Han Liu, G. Ghartey-Kwansah, G. Ren, 2020, EXCLI journal.

FGF21 treatment ameliorates alcoholic fatty liver through activation of AMPK-SIRT1 pathway.

Bing Zhou, X. Ye, G. Ren, 2014, Acta biochimica et biophysica Sinica.

A recombinant avian antibody against VP2 of infectious bursal disease virus protects chicken from viral infection.

Xiaomei Wang, X. Qi, X. Ye, 2017, Research in veterinary science.

Treatment of CIA Mice with FGF21 Down-regulates TH17-IL-17 Axis

Deshan Li, Wen-Fei Wang, Si-ming Li, 2015, Inflammation.

Fibroblast growth factor 21 attenuates hepatic fibrogenesis through TGF-β/smad2/3 and NF-κB signaling pathways.

Liying Song, G. Ren, Deshan Li, 2016, Toxicology and applied pharmacology.

An immuno-blocking agent targeting IL-1β and IL-17A reduces the lesion of DSS-induced ulcerative colitis in mice

Han Liu, Siyu Li, G. Ren, 2021, Inflammation.

Fibroblast growth factor (FGF21) protects mouse liver against d-galactose-induced oxidative stress and apoptosis via activating Nrf2 and PI3K/Akt pathways

Liying Song, G. Ren, Deshan Li, 2015, Molecular and Cellular Biochemistry.

A recombinant IgG-like bispecific antibody acting as interleukin-1β and interleukin-17A inhibitor exhibits a promising efficacy for rheumatoid arthritis.

Qiang Wu, Liying Song, Xiaochen Guo, 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Newcastle disease virus expressing an angiogenic inhibitor exerts an enhanced therapeutic efficacy in colon cancer model

Deshan Li, Fanrui Meng, Yu Zhang, 2021, PloS one.

Anchored periplasmic expression (APEx)-based bacterial display for rapid and high-throughput screening of B cell epitopes

X. Ye, G. Ren, Deshan Li, 2014, Biotechnology Letters.

Recombinant Newcastle disease virus expressing human TRAIL as a potential candidate for hepatoma therapy

Zhenyu Zhang, Qingzhong Yu, X. Ye, 2017, European journal of pharmacology.

Chimeric anti-IL-17 full-length monoclonal antibody is a novel potential candidate for the treatment of rheumatoid arthritis.

G. Ren, Deshan Li, Yin-hang Yu, 2014, International journal of molecular medicine.

Recombinant Newcastle Disease Virus Encoding IL-12 and/or IL-2 as Potential Candidate for Hepatoma Carcinoma Therapy

Xu Zhang, G. Ren, Deshan Li, 2016, Technology in cancer research & treatment.

Fibroblast growth factor 21: a novel long-acting hypoglycemic drug for canine diabetes

G. Ren, Deshan Li, Y. Opoku, 2020, Naunyn-Schmiedeberg's Archives of Pharmacology.

Fibroblast Growth Factor 21 Ameliorates Hyperuricemic Nephropathy by Improving Oxidative Stress through Activating Akt/Nrf2 Signaling Pathway

G. Ren, Deshan Li, Y. Opoku, 2021 .

A novel bispecific antibody alleviates bleomycin-induced systemic sclerosis injury.

Han Liu, G. Ren, Deshan Li, 2020, International immunopharmacology.

Recombinant Newcastle disease virus expressing P53 demonstrates promising antitumor efficiency in hepatoma model

Xiaochen Guo, Hongsong Wu, G. Ren, 2016, Journal of Biomedical Science.

Neutralizing scFv Antibodies against Infectious Bursal Disease Virus Isolated From a Nlpa-Based Bacterial Display Library

Liming Xu, Xiaochen Guo, Deshan Li, 2017 .

Screening scFv antibodies against infectious bursal disease virus by co-expression of antigen and antibody in the bacteria display system.

Qiang Wu, Xiaochen Guo, Shengqi Zhang, 2016, Veterinary immunology and immunopathology.

Astragalus polysaccharides attenuated inflammation and balanced the gut microflora in mice challenged with Salmonella typhimurium.

A. Shan, Deshan Li, C. Bi, 2019, International immunopharmacology.

FGF-21 as a novel metabolic regulator.

J. Gromada, G. Sandusky, F. Mehrbod, 2005, The Journal of clinical investigation.

Recombinant Newcastle Disease virus Expressing IL15 Demonstrates Promising Antitumor Efficiency in Melanoma Model

Qingzhong Yu, Dan Yu, G. Ren, 2015, Technology in cancer research & treatment.

Therapeutic Role of Fibroblast Growth Factor 21 (FGF21) in the Amelioration of Chronic Diseases

G. Ren, Deshan Li, Y. Opoku, 2019, International Journal of Peptide Research and Therapeutics.

Ethyl pyruvate protects against Salmonella intestinal infection in mice through down-regulation of pro-inflammatory factors and inhibition of TLR4/MAPK pathway.

A. Shan, Deshan Li, N. Dong, 2019, International immunopharmacology.

Removing residual DNA from Vero-cell culture-derived human rabies vaccine by using nuclease.

Deshan Li, Wen-Fei Wang, Si-ming Li, 2014, Biologicals : journal of the International Association of Biological Standardization.

Therapeutic effect and mechanism of combined use of FGF21 and insulin on diabetic nephropathy.

G. Ren, Deshan Li, Fanrui Meng, 2021, Archives of biochemistry and biophysics.

Improving hyperglycemic effect of FGF‐21 is associated with alleviating inflammatory state in diabetes

Xu Zhang, Xiaochen Guo, Deshan Li, 2018, International immunopharmacology.

Long-acting hypoglycemic effects of PEGylated FGF21 and insulin glargine in mice with type 1 diabetes.

X. Ye, Qiang Wu, G. Ren, 2015, Journal of diabetes and its complications.

Long-lasting anti-diabetic efficacy of PEGylated FGF-21 and liraglutide in treatment of type 2 diabetic mice

Dan Yu, X. Ye, Qiang Wu, 2015, Endocrine.

The bispecific antibody aimed at the vicious circle of IL-1β and IL-17A, is beneficial for the collagen-induced rheumatoid arthritis of mice through NF-κB signaling pathway.

Dan Yu, X. Ye, Qiang Wu, 2016, Immunology letters.

The recombinant Newcastle disease virus Anhinga strain expressing human TRAIL exhibit antitumor effects on a glioma nude mice model

Qingzhong Yu, J. Qi, Deshan Li, 2020, Journal of medical virology.

Newcastle disease virus chimeras expressing the Hemagglutinin- Neuraminidase protein of mesogenic strain exhibits an enhanced anti-hepatoma efficacy.

Dan Yu, Ruixiang Che, Liying Song, 2016, Virus research.

Enhancement of anti-tumor activity of Newcastle disease virus by the synergistic effect of cytosine deaminase.

Wei Wu, G. Ren, Deshan Li, 2013, Asian Pacific journal of cancer prevention : APJCP.

Correction: Identification of Optimal Insertion Site in Recombinant Newcastle Disease Virus (rNDV) Vector Expressing Foreign Gene to Enhance Its Anti-Tumor Effect

Ruixiang Che, Xiaochen Guo, Deshan Li, 2017, PloS one.

Identification of Optimal Insertion Site in Recombinant Newcastle Disease Virus (rNDV) Vector Expressing Foreign Gene to Enhance Its Anti-Tumor Effect

Ruixiang Che, Xiaochen Guo, Deshan Li, 2016, PloS one.

Oncolytic Newcastle disease virus expressing the co-stimulator OX40L as immunopotentiator for colorectal cancer therapy

Zhenzhong Wang, G. Ren, Deshan Li, 2021, Gene Therapy.

[Construction of expression vectors for efficient expression of soluble recombinant proteins].

G. Ren, Deshan Li, Huimeng Zhu, 2010, Sheng wu gong cheng xue bao = Chinese journal of biotechnology.

FGF21 ameliorates nonalcoholic fatty liver disease by inducing autophagy

Yuquan Wei, Dan Yu, X. Ye, 2016, Molecular and Cellular Biochemistry.

FGF21 attenuates neurodegeneration through modulating neuroinflammation and oxidant-stress.

W. Xiao, G. Ren, Deshan Li, 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

FGF21 Attenuates Neurodegeneration though Reducing Neuroinflammation and Oxidant-stress

G. Ren, Deshan Li, Mengxia Wang, 2019 .

Fibroblast growth factor 21 protects mouse brain against d-galactose induced aging via suppression of oxidative stress response and advanced glycation end products formation

G. Ren, Deshan Li, Wen-Fei Wang, 2015, Pharmacology Biochemistry and Behavior.

FGF21 alleviates chronic inflammatory injury in the aging process through modulating polarization of macrophages.

W. Xiao, Dan Yu, G. Ren, 2021, International immunopharmacology.

Fibroblast growth factor (FGF21) protects mouse liver against d-galactose-induced oxidative stress and apoptosis via activating Nrf2 and PI3K/Akt pathways

Liying Song, G. Ren, Deshan Li, 2015, Molecular and Cellular Biochemistry.

Pharmacological efficacy of FGF21 analogue, liraglutide and insulin glargine in treatment of type 2 diabetes.

Dan Yu, X. Ye, Qiang Wu, 2017, Journal of diabetes and its complications.

Stability and Glucose Regulation of FGF21 After Modified With Arginines*: Stability and Glucose Regulation of FGF21 After Modified With Arginines*

X. Ye, Deshan Li, Wen-Fei Wang, 2012 .

Cloning, Expression and Purification of Mouse Fibroblast Growth Factor-21 and Its Function in Adipocyte Glucose Metabolism*: Cloning, Expression and Purification of Mouse Fibroblast Growth Factor-21 and Its Function in Adipocyte Glucose Metabolism*

G. Ren, Deshan Li, Wen-Fei Wang, 2009 .

Fibroblast Growth Factor Receptor-2 Involved in FGF-21-mediated Glucose Metabolism*: Fibroblast Growth Factor Receptor-2 Involved in FGF-21-mediated Glucose Metabolism*

G. Ren, Deshan Li, Wen-Fei Wang, 2009 .

Treatment of CIA Mice with FGF21 Down-regulates TH17-IL-17 Axis

Deshan Li, Wen-Fei Wang, Si-ming Li, 2016, Inflammation.

FGF-21 Elevated IL-10 Production to Correct LPS-Induced Inflammation

Deshan Li, Wen-Fei Wang, M. Khoso, 2018, Inflammation.

Fibroblast growth factor 21 ameliorates high glucose-induced fibrogenesis in mesangial cells through inhibiting STAT5 signaling pathway.

Xiaochen Guo, Shengqi Zhang, G. Ren, 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Selection of affinity-improved neutralizing human scFv against HBV PreS1 from CDR3 VH/VL mutant library.

Xiaochen Guo, G. Ren, Deshan Li, 2016, Biologicals : journal of the International Association of Biological Standardization.

Recombinant Newcastle disease virus expressing P53 demonstrates promising antitumor efficiency in hepatoma model

Xiaochen Guo, Hongsong Wu, G. Ren, 2016, Journal of Biomedical Science.

[Antitumor activity of the recombinant rClone30-CD/5-FC system].

Wei Wu, G. Ren, Deshan Li, 2013, Yao xue xue bao = Acta pharmaceutica Sinica.

The immune enhancement effects of recombinant NDV expressing chicken granulocyte-macrophage colony stimulating factor on the different avian influenza vaccine subtypes.

Xiaochen Guo, G. Ren, Deshan Li, 2020, Transboundary and emerging diseases.

Bi-specific antibodies with high antigen-binding affinity identified by flow cytometry.

Liming Xu, G. Ren, Deshan Li, 2015, International Immunopharmacology.

Anchored periplasmic expression (APEx)-based bacterial display for rapid and high-throughput screening of B cell epitopes

X. Ye, G. Ren, Deshan Li, 2014, Biotechnology Letters.

A neutralization scFv antibody against IL-1β isolated from a NIPA-based bacterial display library.

Liming Xu, X. Ye, G. Ren, 2013, Current pharmaceutical biotechnology.

[Establishment of bacteria display technology for Fab antibody library screening].

G. Ren, Deshan Li, L. Ding, 2011, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology.

Fibroblast growth factor (FGF)-21 signals through both FGF receptor-1 and 2

G. Ren, Deshan Li, Jiechao Yin, 2010, Science China Life Sciences.

scFv antibodies against infectious bursal disease virus isolated from a combinatorial antibody library by flow cytometry

Deshan Li, M. Guo, Jing-zhuang Zhao, 2014, Biotechnology Letters.

The pharmacological efficacy of the anti-IL17 scFv and sTNFR1 bispecific fusion protein in inflammation mouse stimulated by LPS.

Dan Yu, Ruixiang Che, Liying Song, 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Efficacy of a combination of high and low dosage of PEGylated FGF-21 in treatment of diabetes in db/db mice.

Liying Song, G. Ren, Deshan Li, 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Comparison of PEGylated FGF-21 with insulin glargine for long-lasting hypoglycaemic effect in db/db mice.

Dan Yu, X. Ye, J. Qi, 2015, Diabetes & metabolism.

FGF-21 Improves Glucose Uptake and Glycogen Synthesis of Insulin-resistant Liver Cells*: FGF-21 Improves Glucose Uptake and Glycogen Synthesis of Insulin-resistant Liver Cells*

G. Ren, Deshan Li, Wen-Fei Wang, 2009 .

Inhibition of Tumor Growth by Polyarginine-Fused Mutant Cytosine Deaminase

Deshan Li, N. Zhang, Wen-Fei Wang, 2015, Applied Biochemistry and Biotechnology.

Fibroblast growth factor 21 (FGF21) ameliorates collagen-induced arthritis through modulating oxidative stress and suppressing nuclear factor-kappa B pathway.

G. Ren, Deshan Li, Zhiyi Zhang, 2015, International immunopharmacology.

FGF-21 Plays a Crucial Role in the Glucose Uptake of Activated Monocytes

Deshan Li, Wen-Fei Wang, Si-ming Li, 2017, Inflammation.